Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro

OBJECTIVES: Recent advances in patient‐derived cancer organoids have opened a new avenue for personalised medicine. We aimed to establish an in vitro technological platform to evaluate chimeric antigen receptor (CAR)‐T cell‐mediated cytotoxicity against bladder cancer. METHODS: Patient‐derived bladd...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lei, Li, Zhichao, Mei, Hongbin, Li, Wujiao, Chen, Dong, Liu, Lisa, Zhang, Zhongfu, Sun, Yangyang, Song, Fei, Chen, Wei, Huang, Weiren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847802/
https://www.ncbi.nlm.nih.gov/pubmed/33552510
http://dx.doi.org/10.1002/cti2.1248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847802/
https://www.ncbi.nlm.nih.gov/pubmed/33552510
http://dx.doi.org/10.1002/cti2.1248

Ejemplares similares